The Valley Desk

ArticleCell insightPublished

Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Lewis Katz School of Medicine, Temple University. Affiliation source

Publication record

Type
Article
Venue
Cell insight
Published
Subject terms
Bladder cancer; preclinical study; Drug Development; Elafibranor; Conditional Reprogramming Cell
PubMed ID
38318161
PubMed Central ID
PMC10840351
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal